Literature DB >> 15118092

Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses.

Chi-Cheng Wu1, Faisal Chawla, Dora Games, Russell E Rydel, Stephen Freedman, Dale Schenk, Warren G Young, John H Morrison, Floyd E Bloom.   

Abstract

Increasing evidence from mouse models of Alzheimer's disease shows that overexpression of a mutant form of the amyloid precursor protein (APP) and its product, beta-amyloid peptide, initiate pathological changes before amyloid deposition. To evaluate the cytological basis for one of these early changes, namely reduced volume of the dentate gyrus (DG), we have used high-throughput diOlistic cell loading and 3D neuronal reconstruction to investigate potential dendritic pathology of granule cells (GCs) in 90-day-old PDAPP mice. Labeled GCs from fixed hippocampal slices were selected randomly and imaged digitally by using confocal laser-scanning microscopy. The dendritic complexity of GCs was quantified according to subordinate morphological parameters, including soma position within the granule cell layer (superficial versus deep) and topographic location within the DG (dorsal versus ventral blade) along the anterior-posterior hippocampal axis. Initial analysis, which included all sampled GC types, revealed a 12% reduction of total dendritic length in PDAPP mice compared with littermate controls. Further analysis, performed with refined subgroups, found that superficially located GCs in the dorsal blade were profoundly altered, exhibiting a 23% loss in total dendritic length, whereas neurons in the ventral blade were unaffected. Superficial GCs were particularly vulnerable (a 32% reduction) in the posterior region of the DG. Furthermore, the dendritic reductions of this select group were uniformly localized within middle-to-outer portions of the dentate molecular layer. We conclude that substantial dendritic pathology is evident in 90-day-old PDAPP mice for a spatially defined subset of GCs well before amyloid accumulation occurs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118092      PMCID: PMC406479          DOI: 10.1073/pnas.0402147101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

Authors:  K Johnson-Wood; M Lee; R Motter; K Hu; G Gordon; R Barbour; K Khan; M Gordon; H Tan; D Games; I Lieberburg; D Schenk; P Seubert; L McConlogue
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Neurotrophic and neuroprotective effects of hAPP in transgenic mice.

Authors:  L Mucke; C R Abraham; E Masliah
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

Review 4.  Hyperactivation of signal transduction systems in Alzheimer's disease.

Authors:  T Saitoh; K Horsburgh; E Masliah
Journal:  Ann N Y Acad Sci       Date:  1993-09-24       Impact factor: 5.691

Review 5.  Mutant genes in familial Alzheimer's disease and transgenic models.

Authors:  D L Price; S S Sisodia
Journal:  Annu Rev Neurosci       Date:  1998       Impact factor: 12.449

Review 6.  Life and death of neurons in the aging brain.

Authors:  J H Morrison; P R Hof
Journal:  Science       Date:  1997-10-17       Impact factor: 47.728

7.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

8.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

9.  Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.

Authors:  Yuesong Gong; Lei Chang; Kirsten L Viola; Pascale N Lacor; Mary P Lambert; Caleb E Finch; Grant A Krafft; William L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

10.  Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.

Authors:  E Masliah; A Sisk; M Mallory; L Mucke; D Schenk; D Games
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

View more
  39 in total

1.  Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Authors:  Owen Carmichael; Jing Xie; Evan Fletcher; Baljeet Singh; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

2.  Functional consequences of the lack of amyloid precursor protein in the mouse dentate gyrus in vivo.

Authors:  Peter Jedlicka; Mirka Owen; Matej Vnencak; Jakob-A Tschäpe; Meike Hick; Ulrike C Müller; Thomas Deller
Journal:  Exp Brain Res       Date:  2011-11-11       Impact factor: 1.972

Review 3.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 4.  The keystone of Alzheimer pathogenesis might be sought in Aβ physiology.

Authors:  D Puzzo; W Gulisano; O Arancio; A Palmeri
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

Review 5.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Truncation of tau at E391 promotes early pathologic changes in transgenic mice.

Authors:  Pamela J McMillan; Brian C Kraemer; Linda Robinson; James B Leverenz; Murray Raskind; Gerard Schellenberg
Journal:  J Neuropathol Exp Neurol       Date:  2011-11       Impact factor: 3.685

7.  Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.

Authors:  Hongxin Dong; Maureen V Martin; Shawn Chambers; John G Csernansky
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

8.  Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease.

Authors:  J Steven Jacobsen; Chi-Cheng Wu; Jeffrey M Redwine; Thomas A Comery; Robert Arias; Mark Bowlby; Robert Martone; John H Morrison; Menelas N Pangalos; Peter H Reinhart; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

9.  Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease.

Authors:  Alon Monsonego; Jaime Imitola; Sanja Petrovic; Victor Zota; Anna Nemirovsky; Rona Baron; Yair Fisher; Trevor Owens; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

10.  Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life.

Authors:  Ganesh M Shankar; Malcolm A Leissring; Anthony Adame; Xiaoyan Sun; Edward Spooner; Eliezer Masliah; Dennis J Selkoe; Cynthia A Lemere; Dominic M Walsh
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.